Paris, France

Jerome Becquart


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 62(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jerome Becquart: Innovator in Therapeutic Albumin Derivatives

Introduction

Jerome Becquart is a notable inventor based in Paris, France. He has made significant contributions to the field of therapeutic agents, particularly through his innovative work on albumin derivatives. His research focuses on utilizing albumin as a stable plasma transporter with therapeutic functions.

Latest Patents

Jerome Becquart holds a patent for "Albumin derivatives with therapeutic functions." This invention describes new therapeutic agents that can be used in the treatment of Acquired Immunodeficiency Syndrome (AIDS). The patent exemplifies hybrid macromolecules composed of albumin derivatives coupled to derivatives of the CD4 receptor, which have a normal or higher affinity for the HIV-1 virus. This groundbreaking work has the potential to enhance treatment options for individuals affected by this disease.

Career Highlights

Jerome Becquart has been associated with Rhone-Poulenc, Inc., where he has furthered his research and development efforts. His work has been instrumental in advancing the understanding of albumin's role in therapeutic applications.

Collaborations

Some of his notable coworkers include Reinhard Fleer and Philippe Hirel. Their collaborative efforts have contributed to the success of his research projects and the development of innovative therapeutic solutions.

Conclusion

Jerome Becquart's contributions to the field of therapeutic albumin derivatives highlight his role as an influential inventor. His patent on albumin derivatives showcases the potential for new treatments in combating diseases like AIDS. His work continues to inspire advancements in medical research and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…